Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verrica Pharmaceuticals (VRCA) Amortizatization of Intangibles (2021 - 2025)

Verrica Pharmaceuticals (VRCA) has 5 years of Amortizatization of Intangibles data on record, last reported at -$23000.0 in Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 107.47% year-over-year to -$23000.0; the TTM value through Dec 2025 reached $352000.0, up 14.29%, while the annual FY2025 figure was $352000.0, 14.29% up from the prior year.
  • Amortizatization of Intangibles reached -$23000.0 in Q4 2025 per VRCA's latest filing, down from $210000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $308000.0 in Q4 2024 and bottomed at -$153000.0 in Q3 2024.
  • Average Amortizatization of Intangibles over 5 years is $60210.5, with a median of $65000.0 recorded in 2022.
  • Peak YoY movement for Amortizatization of Intangibles: tumbled 307.25% in 2023, then skyrocketed 440.0% in 2025.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$52000.0 in 2021, then skyrocketed by 234.62% to $70000.0 in 2022, then surged by 308.57% to $286000.0 in 2023, then grew by 7.69% to $308000.0 in 2024, then plummeted by 107.47% to -$23000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were -$23000.0 in Q4 2025, $210000.0 in Q3 2025, and $81000.0 in Q2 2025.